TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05840341

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QingyiHuaji optimized formula
Description: Qingyihuaji Optimization Formula each bag contains: (1)Scutellaria barbata D. Don (Banzhilian); (2) Hedyotis diffusa Willd. (Sheshecao); (3) Amorphophallus rivieri Durieu (Sheliugu); (4) Amomi Fructus Rotundus (Doukou); (5) Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan); (6) Semen Coicis (Yiyiren); (7) Ganoderma lucidum (Curtis) P. Karst. (Lingzhi). One bag at a time, twice a day, rinsing with boiling water, continuous administration, oral administration in the morning and evening, every 3 weeks as a cycle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: QingyiHuaji optimized formula
Description: Qingyihuaji Optimization Formula each bag contains: (1)Scutellaria barbata D. Don (Banzhilian); (2) Hedyotis diffusa Willd. (Sheshecao); (3) Amorphophallus rivieri Durieu (Sheliugu); (4) Amomi Fructus Rotundus (Doukou); (5) Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan); (6) Semen Coicis (Yiyiren); (7) Ganoderma lucidum (Curtis) P. Karst. (Lingzhi). One bag at a time, twice a day, rinsing with boiling water, continuous administration, oral administration in the morning and evening, every 3 weeks as a cycle.
Study: NCT04383314

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 10-week exercise program on HA accumulation
Description: A 10-week exercise program with both aerobic and resistance components, based on the American College of Sports Medicine (2010), will be individually prescribed to 25 T2DM patients.Exercise training will be performed on Days 1 and 2 of each week under the supervision of licensed physical therapists. Participants will have the choice of using a treadmill or a recumbent stepper. The physical therapists will monitor blood glucose level, blood pressure, heart rate, and RPE during each exercise session. Participants will be asked to exercise at home on Day 3 of each week, and will not be supervised by the study team.
Study: NCT05898750

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MorDom
Description: oral powder in tea bags contains 4gm twice daily (equal concentration of each drugs)
Study: NCT05473598

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: All patients, regardless of condition, will have access to usual care for hazardous drinking in primary care. In this setting, usual care entails a spectrum of alcohol-related services including annual screening for hazardous drinking, brief intervention following a positive screen (advice from a provider to reduce their drinking), and referral (as needed) to specialty AUD treatment.
Study: NCT04911699

Intervention type: BEHAVIORAL
Intervention: breast adenocarcinoma receiving chemotherapy
Description: for chemotherapy
Study: NCT04846387

Intervention type: DIAGNOSTIC_TEST
Intervention: Post-Void Residual
Description: The patient's post-void residual is determined using a portable ultrasound machine after emptying the bladder just prior to entering the MRI scanner and immediately after the MRI scan.

Intervention type: DIAGNOSTIC_TEST
Intervention: Post-Void Residual
Description: The patient's post-void residual is determined using a portable ultrasound machine after emptying the bladder just prior to entering the MRI scanner and immediately after the MRI scan.
Study: NCT04911699

Intervention type: BEHAVIORAL
Intervention: Control-for
Description: hormonal drug treatment
Study: NCT05605977

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional visual-motor training program
Description: Traditional visual-motor program includes play and paper-and-pencil activities

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerized visual-motor training program
Description: Computerized visual-motor training program includes tablet visual-motor games
Study: NCT04552717

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: My Grief
Description: The app will build on principles of cognitive behavioural theory and therapy (CBT) and contains four main sections: Learning, Self-assessment, Manage symptoms and Find support.
Study: NCT05496218

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: At study entry, we will collect morning blood samples from fasting women. participants will be asked with an interview on demographic and lifestyle characteristics, health-related behaviours, the existence and duration of infertility, medical history, and history of hormonal or surgical treatments for endometriosis. Pain symptoms before surgery will be evaluated through a 10 cm long one-dimensional visual-analogue scale (VAS). In addition, women will be asked to report about their usual weekly food consumption in the previous year. Information on the diet will be based on a reproducible and valid food frequency questionnaire. Energy and mineral and macro-and micronutrient intakes will be estimated using the most recent update of an Italian Food Consumption Database.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: At study entry, we will collect morning blood samples from fasting women. participants will be asked with an interview on demographic and lifestyle characteristics, health-related behaviours, the existence and duration of infertility, medical history, and history of hormonal or surgical treatments for endometriosis. Pain symptoms before surgery will be evaluated through a 10 cm long one-dimensional visual-analogue scale (VAS). In addition, women will be asked to report about their usual weekly food consumption in the previous year. Information on the diet will be based on a reproducible and valid food frequency questionnaire. Energy and mineral and macro-and micronutrient intakes will be estimated using the most recent update of an Italian Food Consumption Database.
Study: NCT05321095

Intervention type: DIAGNOSTIC_TEST
Intervention: Albuminuria test
Description: During participation, subjects are asked to collect one or more urine samples for albuminuria determination.

Intervention type: DIAGNOSTIC_TEST
Intervention: HbA1c test
Description: During the screening visit, HbA1c will be measured with a point-of-care test (Affinion HbA1c, Abbott).

Intervention type: DIAGNOSTIC_TEST
Intervention: Creatinine test
Description: During the screening visit, creatinine will be measured with a point-of-care test (i-STAT Alinity handheld analyser, Abbott).
Study: NCT04846387

Intervention type: DIAGNOSTIC_TEST
Intervention: Uroflowmetry
Description: Patients will urinate into a funnel connected to an electric flow meter to record urine flow rates in mililters per second. This is used as part of the screening process.
Study: NCT05000463

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ozone
Description: The participants will lay flat and the area of injection will be prepared with antiseptic. Maintenance of ultrasonography probe sterility was also guaranteed using a sterile barrier. Under sonographic guidance, superficial peroneal nerve, deep peroneal, sural , asphenous, and tibila nerves will be injected An ozone/oxygen mixture ( 25μg/ml) will be injected in each nerev

Intervention type: DRUG
Group type: OTHER
Intervention: Convtrol group
Description: The medical treatment included optimal glycemic control, vitamin B complex, a lipoic acid, selective serotonin reuptake inhibitors, and pregabalin.
Study: NCT05953311

Intervention type: OTHER
Intervention: Blood analysis
Description: Blood analysis for neurological biomarkers measurements

Intervention type: OTHER
Intervention: Cognitive tests
Description: Questionnaires assessing cognitive function
Study: NCT04846387

Intervention type: BEHAVIORAL
Intervention: Questionaire - AUA Symptom Score
Description: Subjects will fill out questionnaire asking about urinary symptoms. The range is 0-35.
Study: NCT04997434

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art-therapy in the emergency department
Description: The intervention will begin with a 5-10 minute interview with the patient to define his or her tastes and contraindications to certain techniques. Since the art-therapeutic intervention that will be proposed seeks to generate pleasant feelings, it will be important to rely on the patient's tastes. At the end of the interview, modern art therapy will be presented to the patient and several artistic activities will be proposed (origami, drawing, creative writing).~Once the activity has been chosen, the patient will have 15 to 20 minutes to carry it out, accompanied by the art therapist according to his/her needs. During the activity, verbal exchanges will continue. After the 15 to 20 minutes of the session, 5 minutes will be devoted to the patient's self-evaluation of the past moment, of his level of anxiety, of the intensity of his pain and of his feelings in relation to his passage in the Emergency Department and the art therapy session.
Study: NCT05855681

Intervention type: OTHER
Group type: OTHER
Intervention: therapeutic exercises
Description: strengthening exercise and stretching exercise
Study: NCT01087138

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: exercise class 3x's/week

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise and calcium
Description: exercise class 3x's/week and 1500mg calcium intake
Study: NCT06043531

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: EVOO
Description: Subjects will consume 50g of cold pressed EVOO per day for 28 days.
Study: NCT05855681

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: therapeutic exercises
Description: strengthening exercise and stretching exercise
Study: NCT04353310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Curcumin
Description: Curcumin 1500mg PO BID
Study: NCT05997186

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgical reconstruction
Description: Surgical reconstruction with a free reinnervated profunda artery perforator flap
Study: NCT06295601

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation
Description: The program consists of a joint treatment in which lower extremity strengthening and balance exercises are carried out synchronously. The program will include a total of 5 minutes of warm-up, 5 minutes of cool-down and 30 minutes of exercises related to the program. The difficulty of the program will increase by changing the number of exercises and increasing the weight in strengthening exercises. Progress in balance and coordination exercises will vary by changing the ground, increasing the standing time, and keeping the eyes open and closed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation
Description: The program consists of a joint treatment in which lower extremity strengthening and balance exercises are carried out synchronously. The program will include a total of 5 minutes of warm-up, 5 minutes of cool-down and 30 minutes of exercises related to the program. The difficulty of the program will increase by changing the number of exercises and increasing the weight in strengthening exercises. Progress in balance and coordination exercises will vary by changing the ground, increasing the standing time, and keeping the eyes open and closed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action observation therapy and motor imagery
Description: In the experimental group, in addition to traditional telerehabilitation, action observation and motor imagery of 4 exercises will be performed in each session. A video will be prepared for 4 exercises. Then, the participant will perform 2 minutes of action observation of each movement, followed by 1 minute of motor imagery. In addition to the traditional telerehabilitation program, a 12-minute combination of action observation and motor imagery will be performed in each session. Exercises will be changed every two weeks, gradually increasing the difficulty.
Study: NCT06138327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMN 255
Description: Oral Capsule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Capsule
Study: NCT04949945

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Help Culturally Cognitive Behavioral Therapy
Description: Experimental group (CHF patients)will be screened on PHQ9 questionnaire for depression after receiving guided self help culturally adapted cognitive therapy they will be reassessed for their depression,improvement in functional disability ,improvement in classification of NYHA,reduction in hospital admission as compare to control group.
Study: NCT05799391

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SJC
Description: Soothing cream jel

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo cream jel
Study: NCT05978336

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Coaching Program
Description: The HC program will be delivered over 26-weeks. Participants will have an initial hour-long HC session where the BAP coach will conduct a brief physical assessment and work with the participant to establish their physical activity goals and develop a plan. After the initial consult, coaches will conduct 8 x 20-minute phone calls with participants over the 26-week trial decreasing from bi-weekly phone calls in weeks 1-12 to monthly phone calls in weeks 13-26.~Participants in the HC group will have an overall goal of increasing their weekly participation in moderate to vigorous physical activity by 50 minutes, via 5-, 7-, or 10-minute bouts of progressive exercises, at a rate of perceived exertion range of 13-14 (somewhat hard) by week 16. Participants will have access to specific exercise sessions made available by YouTube and/or hardcopy manuals created by the research team.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education Program
Description: Participants will begin with a one-hour, group-based, interactive education session on falls prevention delivered either in-person or by Zoom. Following the initial education session, ED participants will receive additional group education sessions (in-person or by Zoom) with the same duration and schedule as the HC program covering a variety of healthy aging topics.
Study: NCT06299592

Intervention type: COMBINATION_PRODUCT
Intervention: PET/MRI using [18F]FEPPA tracer
Description: PET/MRI scans with \[18F\]FEPPA radiotracer selective for translocator protein (TSPO) binding, which is elevated in activated microglia

Intervention type: COMBINATION_PRODUCT
Intervention: PET/MRI using [18F]FEPPA tracer
Description: PET/MRI scans with \[18F\]FEPPA radiotracer selective for translocator protein (TSPO) binding, which is elevated in activated microglia
Study: NCT05731271

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TST003
Description: IV humanized anti-GREM1 monoclonal antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TST003
Description: IV humanized anti-GREM1 monoclonal antibody
Study: NCT00545207

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ibandronate [Bonviva/Boniva]
Description: 150mg po monthly for 2 years

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: po monthly for 2 years
Study: NCT06229587

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: furlow with buccinator flap
Description: Assessment of speech and the middle ear function of patients between the age of 3 and 7 years surgically treated by ARC (Furlow z-palatoplasty with a buccinator myomucosal flap) was done
Study: NCT04353310

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: identical in appearance to curcumin
Study: NCT05091411

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant new coronavirus vaccine (CHO cell) group
Description: Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person doseRecombinant new coronavirus vaccine (CHO cells).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant new coronavirus vaccine (CHO cell) group
Description: Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person doseRecombinant new coronavirus vaccine (CHO cells).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant new coronavirus vaccine (CHO cell) group
Description: Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person doseRecombinant new coronavirus vaccine (CHO cells).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant new coronavirus vaccine (CHO cell) group
Description: Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person doseRecombinant new coronavirus vaccine (CHO cells).
Study: NCT06316726

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: full bed silicone mattress plus other measures
Description: full bed silicone mattress plus put silicone pads on the head and shoulders, cotton rolls wraps bony prominence (elbows and heels), petrissage every two hours on shoulders to fingers and lower legs to heels, change location of ankle pads, use round gel full of air sit pad, a pillow on the knees
Study: NCT04973358

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: buccotherm mouthwash
Description: twice a day for 14 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo mouthwash
Description: twice a day for 14 weeks
Study: NCT04528030

Intervention type: DEVICE
Group type: OTHER
Intervention: WAVE device
Description: WAVE applies a transcutaneous vibration to the soles of the foot and palms of the hand to elicit nerve signalling from pressure and other limb proprioceptor sensors to pontine, cerebellar, and medullary brain areas that coordinate limb movement and reflexively activate brain areas controlling breathing. The WAVE device is a battery-operated product to reduce the episodes of Apnoea of Prematurity by vibratory stimulation to the hand and foot.

Intervention type: DEVICE
Group type: OTHER
Intervention: WAVE device
Description: WAVE applies a transcutaneous vibration to the soles of the foot and palms of the hand to elicit nerve signalling from pressure and other limb proprioceptor sensors to pontine, cerebellar, and medullary brain areas that coordinate limb movement and reflexively activate brain areas controlling breathing. The WAVE device is a battery-operated product to reduce the episodes of Apnoea of Prematurity by vibratory stimulation to the hand and foot.
Study: NCT06198036

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hold-Relax Technique
Description: Participants in this group will be treated with hold-relax PNF Technique

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Muscle Energy Technique
Description: Participants in this group will be treated with Muscle Energy Technique via Reciprocal Inhibition Mechanism
Study: NCT05102136

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN9933
Description: Administered intravenously (IV) or subcutaneous (SC) per the protocol
Study: NCT04618926

Intervention type: DEVICE
Intervention: Device intubating Laryngeal Tube Suction Disposable
Description: Resuscitation in covid 19 patients

Intervention type: DEVICE
Intervention: Device intubating Laryngeal Tube Suction Disposable
Description: Resuscitation in covid 19 patients
Study: NCT05909137

Intervention type: RADIATION
Intervention: IMRT+adjuvant immunotherapy
Description: The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT and the control group with CTV-delineated IMRT using a random number table.

Intervention type: RADIATION
Intervention: IMRT+adjuvant immunotherapy
Description: The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT and the control group with CTV-delineated IMRT using a random number table.
Study: NCT05102136

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN9933
Description: Administered intravenously (IV) or subcutaneous (SC) per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match REGN9933 in same form; placebo administered IV or SC per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match REGN9933 in same form; placebo administered IV or SC per the protocol
Study: NCT05719207

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Balloon dilation of eustachian tube (Stryker XprESS LoProfile ENT dilation system)
Description: Patients in the intervention group would undergo balloon dilation of the eustachian tube under local anesthetic in clinic. The Stryker XprESS LoProfile ENT dilation system will be used. Participants may undergo dilation under general anesthesia if a contraindication to in-clinic dilation exists.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: Patients in the sham group will undergo the motions of an in-office dilation of the eustachian tube, without actually dilating the eustachian tube.
Study: NCT05447689

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative-Mind-Body Skills Group
Description: Integrative-Mind-Body Skills Group (I-MBS-G) is an 8-week group that teaches skills to build inner resources for effective mood management. This group incorporates a holistic approach to wellness through meditation and mindfulness practices, guided imagery, breath and body awareness, relaxation techniques, self-reflection, and mindfulness-based cognitive-behavioral skills. Mind-body approaches have demonstrated effectiveness in reducing stress mood symptoms and improving quality of life.
Study: NCT04764721

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET-CT
Description: Enrolled patients in Neurocog-Covid will receive a 18F-FDG PET-CT
Study: NCT06024187

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cold dissection
Description: The subcutaneous flap dissection was performed with a scissor in this group. The boundary of mastectomy flap was defined as the edge of clavicle superiorly, the edge of sternum medially, the edge of inframammary fold inferiorly, and the edge of the latissimus dorsi laterally. Our tumescent technique utilizes a solution made by mixing 0.2ml of epinephrine with 250 ml of 0.9% Sodium Chloride solution to create a 1‰ ratio. 150ml to 150ml of the solution was injected into the subcutaneous tissue of the operated breast with a 20-gauge spinal needle to establish a bloodless plane. The septa between the skin flap and parenchyma then was dissected using a scissor.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrocautery Dissection
Description: The subcutaneous flap dissection was performed with electrocautery in this group. The boundary of mastectomy flap was defined as the edge of clavicle superiorly, the edge of sternum medially, the edge of inframammary fold inferiorly, and the edge of the latissimus dorsi laterally.
Study: NCT05631262

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB264
Description: Subjects of Cohot 1-5 and Part II Test group will receive SKB264 monotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB264
Description: Subjects of Cohot 1-5 and Part II Test group will receive SKB264 monotherapy
Study: NCT06112470

Intervention type: OTHER
Intervention: Interview
Description: Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.